A neurological rarity not to be missed: Cerebrotendinous xanthomatosis

Practical Neurology

Volumn 11, Issue 5, 2011, Pages 296-300

  Rafiq, M ^a,b   Sharrack, N ^c   Shaw, P J ^a,b   Hadjivassiliou, M ^a  

^a ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

^c UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL;

ADULT; ARTICLE; CASE REPORT; CEREBELLUM; CEREBROTENDINOUS XANTHOMATOSIS; FEMALE; HUMAN; MALE; METABOLISM; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PATHOPHYSIOLOGY;

ADULT; CEREBELLUM; CHOLESTEROL; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; XANTHOMATOSIS, CEREBROTENDINOUS;

EID: 80052831066     PISSN: 14747758     EISSN: 14747766     Source Type: Journal    
DOI: 10.1136/practneurol-2011-000003     Document Type: Article

References (6)

1. Gallus GN, Dotti MT, Federico A. Clinical and molecular diagnosis of cerebrotendinous xanthomatosis with a review of the mutations in the CYP27A1 gene. Neurol Sci 2006;27:143-149.
2. Verrips A, van Engelen BG, Wevers RA, et al. Presence of diarrhea and absence of tendon xanthomas in patients with cerebrotendinous xanthomatosis. Arch Neurol 2000;57:520-524.
3. Frederico A, Dotti MT, Gallus GN. Cerbrotendinous Xanthomatosis: Gene Reviews. 2010. http://www.ncbi.nlm.nih.gov/books/NBK1409 (accessed 19 Aug 2011).
4. Berginer VM, Salen G, Shefer S. Long-term treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid. N Engl J Med 1984;311:1649-1652.
5. Guerrera S, Stromillo ML, Mignarri A, et al. Clinical relevance of brain volume changes in patients with cerebrotendinous xanthomatosis. J Neurol Neurosurg Psychiatr 2010;81: 1189-1193.
6. De Stefano N, Dotti MT, Mortilla M, et al. Magnetic resonance imaging and spectroscopic changes in brains of patients with cerebrotendinous xanthomatosis. Brain 2001;124:121-131